Sofinnova Investments as of March 31, 2024
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 7.9 | $142M | 1.6M | 91.46 | |
| Vera Therapeutics Cl A (VERA) | 6.7 | $121M | 2.8M | 43.12 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 6.3 | $114M | 754k | 151.17 | |
| Aerovate Therapeutics (AVTE) | 6.2 | $111M | 3.8M | 29.57 | |
| Merck & Co (MRK) | 4.8 | $86M | 651k | 131.95 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.5 | $81M | 850k | 94.89 | |
| Novo-Nordisk A S Adr (NVO) | 4.4 | $79M | 612k | 128.40 | |
| Incyte Corporation (INCY) | 4.2 | $76M | 1.3M | 56.97 | |
| Argenx SE Sponsored Adr (ARGX) | 3.3 | $59M | 149k | 393.72 | |
| Intuitive Surgical (ISRG) | 3.1 | $56M | 141k | 399.09 | |
| Dyne Therapeutics (DYN) | 3.1 | $55M | 1.9M | 28.39 | |
| Inhibrx | 2.5 | $46M | 1.3M | 34.96 | |
| Elanco Animal Health (ELAN) | 2.3 | $42M | 2.6M | 16.28 | |
| IDEXX Laboratories (IDXX) | 2.3 | $41M | 75k | 539.93 | |
| AstraZeneca Sponsored Adr (AZN) | 2.3 | $40M | 597k | 67.75 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $38M | 1.6M | 23.80 | |
| Insulet Corporation (PODD) | 2.1 | $38M | 220k | 171.40 | |
| Y Mabs Therapeutics (YMAB) | 2.0 | $36M | 2.2M | 16.26 | |
| Ideaya Biosciences (IDYA) | 1.9 | $34M | 782k | 43.88 | |
| Celldex Therapeutics (CLDX) | 1.9 | $34M | 802k | 41.97 | |
| Inozyme Pharma (INZY) | 1.8 | $33M | 4.3M | 7.66 | |
| Align Technology (ALGN) | 1.7 | $31M | 96k | 327.92 | |
| Arrivent Biopharma (AVBP) | 1.7 | $30M | 1.7M | 17.86 | |
| Tg Therapeutics (TGTX) | 1.7 | $30M | 2.0M | 15.21 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $30M | 228k | 129.46 | |
| Marinus Pharmaceuticals (MRNS) | 1.6 | $29M | 3.3M | 9.04 | |
| Boston Scientific Corporation (BSX) | 1.4 | $24M | 354k | 68.49 | |
| Immatics NV SHS (IMTX) | 1.3 | $23M | 2.2M | 10.51 | |
| Silk Road Medical Inc Common (SILK) | 1.2 | $22M | 1.2M | 18.32 | |
| Cogent Biosciences (COGT) | 0.9 | $16M | 2.4M | 6.72 | |
| EXACT Sciences Corporation (EXAS) | 0.9 | $16M | 230k | 69.06 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $15M | 103k | 149.45 | |
| Immunome (IMNM) | 0.8 | $15M | 594k | 24.68 | |
| Pharvaris N V (PHVS) | 0.8 | $14M | 585k | 23.11 | |
| Savara (SVRA) | 0.7 | $12M | 2.3M | 4.98 | |
| Shockwave Med | 0.6 | $11M | 35k | 325.63 | |
| Kura Oncology (KURA) | 0.6 | $11M | 502k | 21.33 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $11M | 1.0M | 10.54 | |
| Axonics Modulation Technolog (AXNX) | 0.6 | $10M | 149k | 68.97 | |
| Pepgen (PEPG) | 0.4 | $7.4M | 504k | 14.70 | |
| Cabaletta Bio (CABA) | 0.4 | $7.3M | 430k | 17.06 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $7.2M | 141k | 50.90 | |
| Achieve Life Sciences (ACHV) | 0.4 | $6.9M | 1.5M | 4.54 | |
| Soleno Therapeutics (SLNO) | 0.4 | $6.5M | 151k | 42.80 | |
| 4d Molecular Therapeutics In (FDMT) | 0.4 | $6.3M | 198k | 31.86 | |
| Nextcure (NXTC) | 0.3 | $6.0M | 2.7M | 2.23 | |
| Avantor (AVTR) | 0.3 | $5.9M | 232k | 25.57 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $5.1M | 19k | 267.04 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $3.9M | 2.8M | 1.40 | |
| Fusion Pharmaceuticals | 0.2 | $3.4M | 157k | 21.32 | |
| Masimo Corporation (MASI) | 0.2 | $2.9M | 20k | 146.85 | |
| Teleflex Incorporated (TFX) | 0.2 | $2.7M | 12k | 226.17 | |
| Insmed Com Par $.01 Call Option (INSM) | 0.2 | $2.7M | 100k | 27.13 | |
| Cooper Cos (COO) | 0.1 | $2.2M | 21k | 101.46 | |
| Inspire Med Sys (INSP) | 0.1 | $1.7M | 8.1k | 214.79 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.7M | 607k | 2.84 | |
| LivaNova SHS (LIVN) | 0.1 | $1.1M | 21k | 55.94 | |
| Nucana Sponsored Adr | 0.0 | $884k | 3.4M | 0.26 | |
| Baxter International (BAX) | 0.0 | $855k | 20k | 42.74 | |
| Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.0 | $853k | 316k | 2.70 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $565k | 143k | 3.96 | |
| IsoRay (CATX) | 0.0 | $512k | 430k | 1.19 | |
| Inari Medical Ord (NARI) | 0.0 | $490k | 10k | 47.98 | |
| Disc Medicine (IRON) | 0.0 | $384k | 6.2k | 62.26 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $374k | 8.7k | 42.86 | |
| Nucana Common Shares | 0.0 | $340k | 1.3M | 0.26 | |
| Kyverna Therapeutics (KYTX) | 0.0 | $248k | 10k | 24.84 | |
| Ikena Oncology (IKNA) | 0.0 | $164k | 116k | 1.42 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $76k | 3.0k | 25.12 |
